Haszon Ibolya, Friedman Aaron L, Papp Ferenc, Bereczki Csaba, Baji Sándor, Bodrogi Tibor, Károly Eva, Endreffy Emöke, Túri Sándor
Department of Pediatrics, University of Szeged, Hungary.
Pediatr Nephrol. 2002 Dec;17(12):1027-31. doi: 10.1007/s00467-002-0968-1. Epub 2002 Nov 14.
The objective of this study was to investigate whether mutations of the renin-angiotensin system genes are involved in primary vesicoureteric reflux (VUR) and VUR-associated renal scarring. The M235T polymorphism of the angiotensinogen ( ATG) gene, the I/D polymorphism of the angiotensin converting enzyme ( ACE) gene, and the A1166C polymorphism of the angiotensin II type 1 receptor ( AT1) gene were identified in 77 patients with primary VUR (aged 6.9+/-3.2 years, mean+/-SD) and 80 healthy controls (aged 33+/-7 years). Thirty-eight of the 77 VUR patients had low-grade VUR (grade I-III) and 39 had high-grade VUR (grade IV and V). Renal scarring was found in 43 VUR patients, while 34 patients had normal kidneys on dimercaptosuccinic acid scan. The ACE gene polymorphism was determined by polymerase chain reaction and the ATG and AT1 gene polymorphisms were determined by single-step LightCycler technology. We found significant over-representation of the DD genotype in patients with renal scarring (44 %) compared with normal controls (23%, P<0.05) and patients with no scar formation (21%, P<0.05). Significantly higher D and significantly lower I allele frequencies were present in VUR patients with scarred kidneys (D allele 0.64 and I allele 0.36) compared with controls (D allele 0.53 and I allele 0.47, P<0.05) and patients with unscarred kidneys (D allele 0.4 and I allele 0.6, P<0.05). No differences in the ATG and AT1 genotype distributions and allele frequencies were observed in VUR patients compared with the normal population. The DD genotype and D allele of ACE may be a genetic susceptibility factor contributing to scar formation in VUR. We detected no linkage of genetic polymorphisms of ATG and AT1 to VUR and VUR-associated renal scarring.
本研究的目的是调查肾素 - 血管紧张素系统基因的突变是否与原发性膀胱输尿管反流(VUR)及VUR相关的肾瘢痕形成有关。在77例原发性VUR患者(年龄6.9±3.2岁,均值±标准差)和80例健康对照者(年龄33±7岁)中,鉴定了血管紧张素原(ATG)基因的M235T多态性、血管紧张素转换酶(ACE)基因的I/D多态性以及血管紧张素II 1型受体(AT1)基因的A1166C多态性。77例VUR患者中,38例为低度VUR(I - III级),39例为高度VUR(IV级和V级)。43例VUR患者发现有肾瘢痕形成,而34例患者在二巯基琥珀酸扫描时肾脏正常。ACE基因多态性通过聚合酶链反应测定,ATG和AT1基因多态性通过单步LightCycler技术测定。我们发现,与正常对照者(23%,P<0.05)和无瘢痕形成的患者(21%,P<0.05)相比,有肾瘢痕形成的患者中DD基因型显著过多(44%)。与对照者(D等位基因0.53,I等位基因0.47,P<0.05)和无瘢痕肾脏的患者(D等位基因0.4,I等位基因0.6,P<0.05)相比,有瘢痕肾脏的VUR患者中D等位基因频率显著更高,I等位基因频率显著更低(D等位基因0.64,I等位基因0.36)。与正常人群相比,未观察到VUR患者中ATG和AT1基因型分布及等位基因频率的差异。ACE的DD基因型和D等位基因可能是导致VUR中瘢痕形成的遗传易感因素。我们未检测到ATG和AT1基因多态性与VUR及VUR相关肾瘢痕形成之间的连锁关系。